BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 28260503)

  • 1. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
    Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
    Chauhan R; Chauhan V; Rao MK; Chaudhary D; Bhagyawant S; Dhaked RK
    Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
    Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing toxin-based vaccines against botulism.
    Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
    Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and development of neutralizing antibodies from synthetic BoNT/B LC and its application in detection of botulinum toxin serotype B.
    Ponmariappan S; Jain S; Sijoria R; Tomar A; Kumar O
    Protein Pept Lett; 2012 Mar; 19(3):288-98. PubMed ID: 21933129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.
    Miethe S; Rasetti-Escargueil C; Avril A; Liu Y; Chahboun S; Korkeala H; Mazuet C; Popoff MR; Pelat T; Thullier P; Sesardic D; Hust M
    PLoS One; 2015; 10(10):e0139905. PubMed ID: 26440796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model.
    Tomic MT; Farr-Jones S; Syar ES; Niemuth N; Kobs D; Hackett MJ; Espinoza Y; Martinez Z; Pham K; Snow DM; Marks JD; Cobb RR
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
    Tremblay JM; Vazquez-Cintron E; Lam KH; Mukherjee J; Bedenice D; Ondeck CA; Conroy MT; Bodt SML; Winner BM; Webb RP; Ichtchenko K; Jin R; McNutt PM; Shoemaker CB
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
    Miethe S; Mazuet C; Liu Y; Tierney R; Rasetti-Escargueil C; Avril A; Frenzel A; Thullier P; Pelat T; Urbain R; Fontayne A; Sesardic D; Hust M; Popoff MR
    PLoS One; 2016; 11(8):e0161446. PubMed ID: 27560688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
    Bakherad H; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Mohammadi M; Ebrahimizadeh W; Safaee Ardakani L; Zare H
    Mol Biotechnol; 2013 Oct; 55(2):159-67. PubMed ID: 23666874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Guo JP; An HJ; Zhang SM; Wang S; Yu WY; Sun ZW
    Vaccine; 2013 May; 31(20):2427-32. PubMed ID: 23583890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.
    Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
    Yang GH; Kim KS; Kim HW; Jeong ST; Huh GH; Kim JC; Jung HH
    Toxicon; 2004 Jul; 44(1):19-25. PubMed ID: 15225558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.